A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia

BACKGROUND: Cancer cachexia is characterized by weight loss and is associated with increased morbidity and mortality in patients with cancer. Anamorelin (ONO‐7643; ANAM) is a novel and selective ghrelin receptor agonist that improves appetite, lean body mass (LBM), body weight, and anorexia. METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Hamauchi, Satoshi, Furuse, Junji, Takano, Toshimi, Munemoto, Yoshinori, Furuya, Ken, Baba, Hideo, Takeuchi, Manabu, Choda, Yasuhiro, Higashiguchi, Takashi, Naito, Tateaki, Muro, Kei, Takayama, Koichi, Oyama, Shusuke, Takiguchi, Toru, Komura, Naoyuki, Tamura, Kazuo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900019/
https://ncbi.nlm.nih.gov/pubmed/31415709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32406
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados